Vitro Biopharma

Vitro Biopharma is an innovative biotechnology company focused on developing Wharton's Jelly-derived cell therapies for the treatment of autoimmune diseases and inflammation. Our goal is to become a leader in developing differentiated candidates for the immunology and inflammation markets in a rapid and efficient manner.